Most importantly, however, the presence of AQP4-IgG permits differentiation between NMO and multiple sclerosis - two conditions that can be difficult to distinguish on clinical grounds and the optimum treatments of which differ - by means of a laboratory test [26-31]. This evidence concerns the gene AQP4 and neuromyelitis optica.